• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Antimicrobial peptides as computational candidates for SARS-CoV-2 papain-like protease inhibition

tetano

Editor, Senior Moderator
Sci Rep

. 2026 Sep 4;16(1):27791.
doi: 10.1038/s41598-026-60957-1.

Antimicrobial peptides as computational candidates for SARS-CoV-2 papain-like protease inhibition​


Erenilson Dos Santos Moreira 1 2 , Sergio Siqueira 2 , Fabricio Santos Barbosa 3 2 , Jailan da Silva Sousa 2 4 , Hugo Mauricio Peña Mercado 5 6 , Tarcisio Silva Melo 2 , Arun Kumar Jaiswal 6 7 4 , Vasco Azevedo 6 4 , Aristóteles Góes-Neto 3 5 4 , Bruno Silva Andrade 8 9 10 11

Affiliations Expand


Abstract​


SARS-CoV-2 papain-like protease (PLpro) remains an attractive antiviral target because of its dual role in viral polyprotein processing and host immune modulation. In this study, we employed an exploratory structure-based computational workflow to identify antimicrobial peptide scaffolds with predicted PLpro-binding potential. A total of 6,615 peptides compiled from public databases were screened using protein-peptide docking, followed by molecular dynamics simulations and end-state binding energy analysis for selected complexes. Among the prioritized candidates, peptides 33,035 and 17,047 showed favorable predicted occupation of the catalytic region and persistent interactions with residues in the active-site environment. Molecular dynamics analyses suggested sustained peptide engagement within the PLpro binding region, although distinct degrees of conformational adaptation were observed across systems. MM/PBSA calculations provided additional energetic support for peptide-PLpro association in the selected complexes. In silico toxicity prediction further indicated that peptide 33,035 may require sequence optimization before translational consideration. Overall, our results identify peptide scaffolds worthy of future biochemical and antiviral validation, while reinforcing the need for experimental confirmation and further optimization before any therapeutic inference can be made.

Keywords: Antimicrobial peptides; MMPBSA; Molecular docking; Molecular dynamics; PLpro; SARS-CoV-2.
 
Back
Top Bottom